Attenuation of cocaine-induced reinstatement of cocaine conditioned place preference by acamprosate

Behavioural Pharmacology

Volumn 17, Issue 4, 2006, Pages 363-367

  Mcgeehan, Andrew J ^a   Olive, Michael Foster ^b  

^a UNIVERSITY OF CALIFORNIA SAN FRANCISCO   (United States)

^b MUSC Center for Drug and Alcohol Programs   (United States)

Author keywords

Acamprosate; Cocaine; Conditioned place preference; Glutamate; Mouse; Reinstatement; Relapse

Indexed keywords

ACAMPROSATE; COCAINE; GLUTAMIC ACID; SODIUM CHLORIDE;

ALCOHOLISM; ANIMAL EXPERIMENT; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG ABUSE; INJECTION; MALE; MONITORING; MOUSE; NEUROTRANSMISSION; NONHUMAN; PLACE PREFERENCE; RELAPSE;

ANIMALS; COCAINE; COCAINE-RELATED DISORDERS; CONDITIONING, OPERANT; EXTINCTION, PSYCHOLOGICAL; GABA MODULATORS; MALE; MICE; MICE, INBRED C57BL; RECURRENCE; TAURINE;

EID: 33747472833     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fbp.0000224384.01863.5f     Document Type: Article

References (46)

1. Bachteler D, Economidou D, Danysz W, Ciccocioppo R, Spanagel R (2005). The effects of acamprosate and neramexane on cue-induced reinstatement of ethanol-seeking behavior in rat. Neuropsychopharmacology 30:1104-1110.
2. Baker DA, McFarland K, Lake RW, Shen H, Tang XC, Toda S, Kalivas PW (2003). Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse. Nat Neurosci 6:743-749.
3. Bardo MT, Neisewander JL, Miller JS (1986). Repeated testing attenuates conditioned place preference with cocaine. Psychopharmacology (Berlin) 89:239-243.
4. Brabant C, Quertemont E, Tirelli E (2005). Influence of the dose and the number of drug-context pairings on the magnitude and the long-lasting retention of cocaine-induced conditioned place preference in C57BL/6J mice. Psychopharmacology (Berlin) 180:33-40.
5. Childress AR, Mozley PD, McElgin W, Fitzgerald J, Reivich M, O'Brien CP (1999). Limbic activation during cue-induced cocaine craving. Am J Psychiatry 156:11-18.
6. Cornish JL, Kalivas PW (2000). Glutamate transmission in the nucleus accumbens mediates relapse in cocaine addiction. J Neurosci 20:RC89 (81-85).
7. Czachowski CL, Legg BH, Samson HH (2001). Effects of acamprosate on ethanol-seeking and self-administration in the rat. Alcohol Clin Exp Res 25:344-350.
8. Dahchour A, De Witte P (2000). Ethanol and amino acids in the central nervous system: assessment of the pharmacological actions of acamprosate. Prog Neurobiol 60:343-362.
9. Dahchour A, De Witte P (2003). Effects of acamprosate on excitatory amino acids during multiple ethanol withdrawal periods. Alcohol Clin Exp Res 27:465-470.
10. Dahchour A, De Witte P, Bolo N, Nédélec JF, Muzet M, Durbin P, Macher JP (1998). Central effects of acamprosate: part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in ethanol withdrawn rats. Psychiatry Res 82:107-114.
11. De Witte P, Littleton J, Parot P, Koob G (2005). Neuroprotective and abstinence-promoting effects of acamprosate: elucidating the mechanism of action. CNS Drugs 19:517-537.
12. Grant KA, Woolverton WL (1989). Reinforcing and discriminative stimulus effects of Ca-acetyl homotaurine in animals. Pharmacol Biochem Behav 32:607-611.
13. Harris BR, Prendergast MA, Gibson DA, Rogers DT, Blanchard JA, Holley RC, et al. (2002). Acamprosate inhibits the binding of neurotoxic effects on trans-ACPD, suggesting a novel site of action at metabotropic glutamate receptors. Alcohol Clin Exp Res 26: 1779-1793.
14. Harris BR, Gibson DA, Prendergast MA, Blanchard JA, Holley RC, Hart SR, et al. (2003). The neurotoxicity induced by ethanol withdrawal in mature organotypic hippocampal slices might involve cross-talk between metabotropic glutamate type 5 receptors and N-methyl-D-aspartate receptors. Alcohol Clin Exp Res 27:1724-1735.
15. Harris GC, Aston-Jones G (2003). Critical role for ventral tegmental glutamate in preference for a cocaine-conditioned environment. Neuropsychopharmacology 28:73-76.
16. Herzig V, Schmidt WJ (2005). Repeated-testing of place preference expression for evaluation of anti-craving-drug effects. Amino Acids 28:309-317.
17. Heyser CJ, Schulteis G, Durbin P, Koob GF (1998). Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats. Neuropsychopharmacology 18:125-133.
18. Isaac WL, Nonneman AJ, Neisewander J, Landers T, Bardo MT (1989). Prefrontal cortex lesions differentially disrupt cocaine-reinforced conditioned place preference but not conditioned taste aversion. Behav Neurosci 103:345-355.
19. Itzhak Y, Martin JL (2002). Cocaine-induced conditioned place preference in mice: induction, extinction and reinstatement by related psychostimulants. Neuropsychopharmacology 26:130-134.
20. Kalivas PW (2004). Glutamate systems in cocaine addiction. Curr Opin Pharmacol 4:23-29.
21. Kalivas PW, Volkow N, Seamans J (2005). Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission. Neuron 45:647-650.
22. Kim S-G, Han B-D, Park J-M, Kim M-J, Stromberg MF (2004). Effect of the combination of naltrexone and acamprosate on alcohol intake in mice. Psychiatry Clin Neurosci 58:30-36.
23. Kratzer U, Schmidt WJ (2003). Acamprosate does not induce a conditioned place preference and reveals no state-dependent effects in this paradigm. Prog Neuropsychopharmacol Biol Psychiatry 27:653-656.
24. Littleton J, Zieglgansberger W (2003). Pharmacological mechanisms of naltrexone and acamprosate in the prevention of relapse in alcohol dependence. Am J Addict 12(Suppl 1):S3-S11.
25. Mangini LD, Bowers M, Chen BT, Bonci A, Janak PH, Olive M (2005). Acamprosate attenuates cocaine-induced reinstatement of cocaine-seeking behavior. In: Program No 800.7, 2005 Abstract Viewer/Itinerary Planner. Washington, District of Columbia: Society for Neuroscience Online.
26. McFarland K, Kalivas PW (2001). The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior. J Neurosci 21:8655-8663.
27. McFarland K, Lapish CC, Kalivas PW (2003). Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior. J Neurosci 23:3531-3537.
28. Mcgeehan AJ, Olive MF (2003a). The anti-relapse compound acamprosate inhibits the development of a conditioned place preference to ethanol and cocaine but not morphine. Br J Pharmacol 138:9-12.
29. Mcgeehan AJ, Olive MF (2003b). The mGluR5 antagonist MPEP reduces the conditioned rewarding effects of cocaine but not other drugs of abuse. Synapse 47:240-242.
30. Mueller D, Stewart J (2000). Cocaine-induced conditioned place preference: reinstatement by priming injections of cocaine after extinction. Behav Brain Res 115:39-47.
31. Myrick H, Anton R (2004). Recent advances in the pharmacotherapy of alcoholism. Curr Psychiatry Rep 6:332-338.
32. Neisewander JL, Baker DA, Fuchs RA, Tran-Nguyen LTL, Palmer A, Marshall JF (2000). Fos protein expression and cocaine-seeking behavior in rats after exposure to a cocaine self-administration environment. J Neurosci 20: 798-805.
33. Olive MF (2005). mGlu5 receptors: neuroanatomy, pharmacology, and role in drug addiction. Curr Psychiatry Rev 1:197-214.
34. Olive MF, Nannini MA, Ou CJ, Koenig HN, Hodge CW (2002). Effects of acute acamprosate and homotaurine on ethanol intake and ethanol-stimulated mesolimbic dopamine release. Eur J Pharmacol 437:55-61.
35. Saivin S, Hulot T, Chabac S, Potgieter A, Durbin P, Houin G (1998). Clinical pharmacokinetics of acamprosate. Clin Pharmacokinet 35:331-345.
36. Sakoori K, Murphy NP (2005). Maintenance of conditioned place preferences and aversion in C57BL6 mice: effects of repeated and drug state testing. Behav Brain Res 160:34-43.
37. Sanchez CJ, Sorg BA (2001). Conditioned fear stimuli reinstate cocaine-induced conditioned place preference. Brain Res 908:86-92.
38. Scott LJ, Figgitt DP, Keam SJ, Waugh J (2005). Acamprosate: a review of its use in the maintenance of abstinence in patients with alcohol dependence. CNS Drugs 19:445-464.
39. Spanagel R, Hölter SM (2000). Pharmacological validation of a new animal model of alcoholism. J Neural Transm 107:669-680.
40. Spanagel R, Pendyala G, Abarca C, Zghoul T, Sanchis-Segura C, Magnone MC, et al. (2005). The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption. Nat Med 11:35-42.
41. Szumlinski KK, Price KL, Frys KA, Middaugh LD (2002). Unconditioned and conditioned factors contribute to the 'reinstatement' of cocaine place conditioning following extinction in C57BL/6 mice. Behav Brain Res 136:151-160.
42. Tzschentke TM, Schmidt WJ (2003). Glutamatergic mechanisms in addiction. Mol Psychiatry 8:373-382.
43. Wilde MI, Wagstaff AJ (1997). Acamprosate: a review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification. Drugs 53:1038-1053.
44. Wolf ME, Sun X, Mangiavacchi S, Chao SZ (2004). Psychomotor stimulants and neuronal plasticity. Neuropharmacology 47(Suppl 1):61-79.
45. Zavala AR, Weber SM, Rice HJ, Alleweireldt AT, Neisewander JL (2003). Role of the prelimbic subregion of the medial prefrontal cortex in acquisition, extinction and reinstatement of cocaine-conditioned place preference. Brain Res 990:157-164.
46. Zornoza T, Cano MJ, Polache A, Granero L (2003). Pharmacology of acamprosate: an overview. CNS Drug Rev 9:359-374.